Understanding the science of photoageing — and how skincare, nutrition, lifestyle changes and modern laser treatments may help restore healthier skin.
When we think about ageing skin, we usually think about wrinkles, pigmentation, sagging and loss of elasticity. But beneath these visible changes, something more important may be happening.
As our skin ages, it can become less effective at protecting itself from ultraviolet (UV) damage and identifying potentially cancerous cells.
This raises an important question: Does our skin’s immune system age, and can years of sun exposure accelerate that process?
The answer is yes.
Recent dermatological research shows that ageing and cumulative UV exposure can alter the skin’s protective mechanisms, including cellular repair, communication between skin cells and local immune surveillance.
The encouraging news is that some of these changes are modifiable. Modern treatments can improve photoaged skin, while certain medical therapies can also reduce precancerous lesions and, in selected patients, future skin cancer risk.
However, improving the appearance of sun damage is not necessarily the same as reversing its biological effects.
1. The Difference Between Natural Ageing and Photoageing
Our skin ages through two overlapping processes.
Intrinsic ageing is the natural biological ageing process influenced by genetics, hormones and time. As we grow older, our skin gradually becomes thinner, produces less collagen, heals more slowly and undergoes changes in its immune function.
Photoageing is the additional damage caused by repeated exposure to ultraviolet radiation, primarily from sunlight.
UV radiation penetrates the skin and triggers several harmful processes:
Direct damage to DNA within skin cells.
Formation of free radicals that damage proteins, lipids and cellular structures.
Breakdown of collagen and elastin.
Chronic inflammation and changes in immune regulation.
Accumulation of ageing, or senescent, cells.
Over time, these processes produce familiar signs of sun damage, including pigmentation, wrinkles, rough texture, broken capillaries and reduced elasticity.
But the deeper concern is that UV exposure also contributes to changes in how skin cells respond to DNA damage.
Photoageing is therefore not simply cosmetic ageing. It is also a biological process that may increase susceptibility to skin cancer.
2. Does Our Skin’s Immune System Age?
Yes. Our skin contains a sophisticated immune network that constantly monitors for infection, abnormal cells and environmental damage.
This includes specialised immune cells such as Langerhans cells, dendritic cells and T lymphocytes.
Under normal circumstances, these immune cells help identify and respond to potentially dangerous changes in skin cells.
As we age, however, this system becomes less well regulated — a process known as immunosenescence.
Importantly, ageing skin does not simply become less inflamed. It may develop chronic low-grade inflammation while simultaneously becoming less effective at mounting certain protective immune responses.
There are four important mechanisms to understand.
A. Ageing fibroblasts accumulate
Fibroblasts are specialised cells within the dermis, the deeper supportive layer of the skin.
They produce collagen, elastin and important signalling molecules that help maintain healthy skin.
As we age, some fibroblasts enter a state called cellular senescence.
These cells are still alive, but they no longer divide normally. They can also release inflammatory molecules that affect surrounding tissue.
Senescent fibroblasts may therefore contribute to:
Reduced collagen production.
Chronic inflammation.
Impaired tissue repair.
Changes in the response of nearby skin cells to UV-induced DNA damage.
These effects help explain why ageing skin can become structurally weaker and biologically less resilient.
B. IGF-1 signalling declines: an important discovery
One of the most interesting discoveries in skin ageing research involves a signalling molecule called insulin-like growth factor 1 (IGF-1).
Healthy dermal fibroblasts produce IGF-1, which communicates with keratinocytes — the predominant cells in the outer layer of the skin.
This signalling helps keratinocytes respond appropriately when their DNA is damaged by UV radiation.
Under normal conditions, damaged cells may stop dividing while protective processes operate. This reduces the chance that damaged DNA will be copied and passed to daughter cells.
As fibroblasts become senescent, however, their production of IGF-1 can decline.
Without sufficient IGF-1 signalling, some UV-damaged keratinocytes may continue dividing when they should not.
In simple terms, ageing can weaken one of the signals that tells a damaged skin cell to stop multiplying.
Researchers have demonstrated this mechanism in laboratory studies and human ageing skin, making it a promising area of skin cancer prevention research.
It does not mean that all older skin is deficient in IGF-1, or that applying IGF-1 directly is an established treatment.
C. Damaged cells may escape protective growth arrest
Every time UV radiation damages skin-cell DNA, the body must decide whether that damage can be repaired or whether the affected cell should stop dividing or be eliminated.
These responses are essential safeguards against cancer.
When the skin’s protective signalling systems become less effective, some damaged cells may survive and replicate.
Repeated exposure creates more opportunities for genetic mutations to accumulate.
Over many years, these changes can contribute to the development of:
Actinic keratoses: rough, scaly precancerous lesions associated with cumulative sun exposure.
Squamous cell carcinoma (SCC): a skin cancer strongly associated with accumulated UV damage.
Basal cell carcinoma (BCC): the most common form of skin cancer, also strongly linked to UV exposure.
Melanoma is also associated with UV-induced DNA damage and immune interactions, although its biology differs from that of BCC and SCC.
D. Immune surveillance becomes less effective
Ageing and UV exposure can affect the activity of T cells and other immune cells responsible for recognising abnormal skin cells.
Chronic UV exposure can also create a local environment that favours immune suppression.
This matters because our immune system plays an important role in recognising and responding to some developing cancers.
As skin immunity changes, potentially abnormal cells may have more opportunity to persist.
It is important to understand that this is not a complete loss of immunity, but rather a complex change in how immune protection is regulated.
Together, these four mechanisms help explain why skin cancer becomes increasingly common with advancing age, particularly in people with substantial lifetime UV exposure.
3. Can We Reverse Sun Damage and Restore Healthier Skin?
This is one of the most exciting areas of modern dermatology.
Although we cannot erase every mutation caused by decades of UV exposure or completely reverse biological ageing, we can improve many aspects of skin health.
The most effective approach combines prevention, appropriate medical skincare, treatment of precancerous changes and, in selected patients, procedures that stimulate skin renewal.
1. Daily Sun Protection: The Foundation of Skin Repair
The most important intervention is preventing additional UV damage.
Even the most advanced laser or skincare treatment cannot compensate for continued excessive sun exposure.
For Australian conditions, a practical approach includes:
Applying broad-spectrum SPF 50 or 50+ sunscreen.
Reapplying every two hours when outdoors, and after swimming or sweating.
Wearing protective clothing, a broad-brimmed hat and sunglasses.
Seeking shade during periods of high UV exposure.
Avoiding tanning beds and intentional tanning.
Sun protection is recommended whenever the UV Index reaches 3 or above.
Regular sunscreen use has been shown to reduce actinic keratoses and cutaneous squamous cell carcinoma. Long-term Australian trial data also support a protective effect against melanoma.
Think of sunscreen as preventing new damage while allowing other treatments to address damage that has already occurred.
2. Topical Skincare: Supporting Repair and Improving Photoageing
Not all anti-ageing skincare works in the same way.
Some ingredients primarily improve hydration and appearance, while others influence collagen production, pigmentation and cellular turnover.
Retinoids: stimulating skin renewal
Topical retinoids, particularly prescription tretinoin, are among the most extensively studied treatments for photoageing.
They can improve fine wrinkles, uneven pigmentation and skin texture while influencing collagen production and epidermal renewal.
Over several months, retinoids can produce measurable improvements in sun-damaged skin.
However, despite their anti-ageing benefits, clinical trials have not demonstrated that topical tretinoin prevents basal or squamous cell carcinomas.
Retinoids should also be avoided during pregnancy, and stronger formulations require consideration of skin sensitivity and irritation.
Vitamin C: antioxidant support
A well-formulated topical vitamin C product may help improve uneven pigmentation, fine lines and collagen-related changes.
Vitamin C also helps counter oxidative stress, one of the consequences of UV exposure.
Although there is evidence for improvement in photoageing, topical vitamin C has not been established as a treatment that prevents skin cancer.
Topical niacinamide: supporting the skin barrier
Niacinamide, a form of vitamin B3, can improve skin barrier function, hydration and some visible signs of photoageing.
It is generally well tolerated, including by people with sensitive or mature skin.
Importantly, topical niacinamide should not be confused with oral nicotinamide, which has been studied separately for skin cancer prevention.
Barrier-repair moisturisers
As skin ages, its ability to retain moisture and maintain a healthy barrier can decline.
Moisturisers containing ceramides, glycerin and other barrier-supporting ingredients can reduce dryness and improve comfort.
A healthier skin barrier supports normal skin function, although moisturisers alone do not reverse DNA mutations or prevent skin cancer.
3. Treating Precancerous Sun Damage
For patients with significant accumulated UV damage, prescription treatments may be necessary.
Actinic keratoses often appear as persistent rough or scaly patches, particularly on the face, scalp, ears, hands and forearms.
They indicate cumulative sun damage and can sometimes progress to squamous cell carcinoma.
Treatments include:
5-fluorouracil (5-FU)
This prescription cream targets abnormal sun-damaged cells across a treatment area.
A randomised trial involving 932 high-risk participants found that a course of topical 5-FU reduced the risk of squamous cell carcinoma requiring surgery on the treated face and ears by approximately 75% during the following year.
The benefit was not sustained across the entire four-year follow-up period, but it provides important evidence that treating sun-damaged fields can reduce short-term cancer risk in selected patients.
Imiquimod
Imiquimod stimulates local immune responses and is an established treatment for actinic keratoses and certain superficial skin cancers.
Photodynamic therapy (PDT)
PDT combines a light-activated medication with an appropriate light source to destroy selected abnormal cells.
It can be useful for treating multiple actinic keratoses over larger areas of sun-damaged skin.
These treatments should be selected and supervised by an appropriately trained clinician. A suspicious lesion may need a biopsy before treatment rather than being treated as routine sun damage.
4. Laser Resurfacing: Can We Rejuvenate the Skin’s Protective Biology?
Traditionally, lasers have been used to improve wrinkles, pigmentation, scars and uneven skin texture.
However, researchers are now investigating whether certain types of laser resurfacing can do more than improve appearance.
In particular, fractional ablative laser resurfacing may alter the aged dermal environment and restore some of the signalling pathways involved in the skin’s protective response to UV damage.
How does fractional laser treatment work?
Fractional resurfacing creates controlled microscopic zones of injury in the skin, leaving surrounding areas intact to support healing.
This stimulates a wound-repair response, with remodelling of the epidermis and dermis.
Depending on the laser system and treatment settings, this may promote collagen remodelling and replacement of some damaged tissue.
Researchers have also observed reductions in senescent fibroblasts and increased dermal IGF-1 expression following certain fractional laser treatments.
What does the research show?
An important randomised clinical trial published in the Journal of Clinical Investigation in 2021 examined fractional laser resurfacing in 48 older adults with substantial sun damage.
Each participant had one forearm treated, while the opposite forearm served as a comparison.
Over follow-up of up to three years, researchers found fewer actinic keratoses and fewer keratinocyte cancers on the laser-treated arms.
There were 2 skin cancers on the treated arms compared with 24 on the untreated arms during the study.
Researchers also found evidence that laser treatment improved the age-related IGF-1 signalling response.
These results are promising because they suggest that controlled skin resurfacing may influence biological pathways associated with skin cancer development — not simply improve wrinkles.
However, this was a relatively small study. Larger trials are needed to determine the size and duration of any protective effect, which patients benefit most and the optimal treatment protocols.
Ablative fractional lasers also differ significantly from non-ablative fractional lasers, pigment lasers and intense pulsed light (IPL). They should not be considered interchangeable for skin cancer prevention.
Is laser treatment right for everyone?
No.
Fractional resurfacing can cause redness, swelling, pigmentation changes, infection or scarring. Risks depend on the device, treatment intensity, skin type and the patient’s health.
Patients with darker skin tones may have an increased risk of post-inflammatory pigmentation changes.
Anyone considering resurfacing of extensively sun-damaged skin should first undergo an appropriate medical skin assessment.
Laser resurfacing is an emerging strategy for biological skin rejuvenation, but it is not currently a substitute for sunscreen, medical treatment of precancerous lesions or regular skin cancer surveillance.
5. Can Diet and Lifestyle Improve Skin Ageing and Immunity?
Healthy skin depends on more than skincare products and procedures.
Nutrition, sleep, smoking, exercise and general health can influence inflammation, wound healing and the maintenance of normal skin structures.
However, it is important to distinguish supporting skin health from claiming to reverse UV-induced mutations.
Eat a varied, nutrient-rich diet
A balanced diet that includes colourful vegetables, fruit, legumes, wholegrains, nuts and healthy fats supplies nutrients needed for normal cellular function.
Particularly relevant nutrients include:
Vitamin C: required for normal collagen synthesis.
Vitamin E and other dietary antioxidants: contribute to protection against oxidative stress.
Omega-3 fatty acids: support normal physiological processes involved in inflammatory regulation.
Protein: provides building blocks for tissue maintenance and repair.
Zinc: contributes to normal immune function and wound healing.
A Mediterranean-style dietary pattern is a reasonable way to obtain many of these nutrients.
However, no particular diet has been proven to reverse established photodamage or reliably prevent skin cancer.
What about supplements?
Supplements are frequently marketed as products that protect against sun damage from within.
The evidence is much less convincing than the advertising often suggests.
Routine high-dose antioxidant supplements have not been shown to provide reliable skin cancer prevention.
One specific exception worth discussing is oral nicotinamide.
Oral nicotinamide: a potential option for high-risk patients
Nicotinamide, a form of vitamin B3, has been studied for its effects on UV-related DNA repair and skin cancer prevention.
In a major Australian randomised trial involving 386 people with a history of multiple non-melanoma skin cancers, nicotinamide 500 mg twice daily reduced the rate of new non-melanoma skin cancers by 23% during 12 months of treatment, compared with placebo.
The benefit was not sustained after treatment stopped.
Importantly, a separate trial in organ-transplant recipients did not demonstrate the same protective benefit.
Nicotinamide is therefore not a universal skin cancer prevention supplement. It may be considered for selected high-risk patients following medical advice.
Other lifestyle factors matter
Avoiding smoking supports skin health because smoking contributes to oxidative stress, collagen damage and impaired wound healing.
Regular physical activity and adequate sleep are beneficial for general health and normal physiological regulation.
However, neither exercise nor better sleep has been proven to reverse existing UV mutations or replace established skin cancer prevention strategies.
6. The Future: Treating the Biology of Ageing Skin
Dermatology is increasingly moving beyond simply treating visible signs of ageing.
Researchers are investigating how to influence the biological environment in which ageing and damaged cells exist.
Areas of interest include:
Reducing the burden or harmful effects of senescent cells.
Restoring healthier communication between fibroblasts and keratinocytes.
Improving protective responses to UV-induced DNA damage.
Modifying age-related inflammation and immune dysfunction.
Developing procedural treatments that may reduce future precancerous and cancerous lesions.
These developments are promising, but many remain experimental.
In particular, there is not yet sufficient evidence that cosmetic skincare products, supplements or routine rejuvenation procedures can comprehensively restore youthful skin immunity.
7. What Should You Do if You Have Significant Sun Damage?
If you have visible photoageing, a history of actinic keratoses, or previous skin cancers, a personalised skin health plan is more useful than relying on a single anti-ageing product.
A sensible approach begins with a thorough skin assessment, followed by a combination of appropriate measures:
Prevent further UV damage with consistent sun protection.
Improve skin quality with evidence-based topical treatments such as retinoids, selected antioxidants and barrier-supporting moisturisers.
Treat precancerous changes using appropriate prescription therapies or procedures.
Consider professional resurfacing treatments where the expected benefits outweigh the risks.
Support general health through balanced nutrition, avoiding smoking and healthy lifestyle habits.
Maintain regular skin surveillance at intervals based on your individual skin cancer risk.
Most importantly, seek medical assessment for any new or changing lesion, a sore that does not heal, or a spot that bleeds, crusts or looks different from your other spots.
Final Thoughts: Skin Rejuvenation Is About More Than Looking Younger
Our understanding of skin ageing is changing.
We now recognise that prolonged sun exposure affects far more than collagen and pigmentation. It can accelerate cellular senescence, alter IGF-1 signalling, contribute to immune dysregulation and create conditions that favour the accumulation of damaged cells.
This helps explain why chronically sun-exposed skin becomes increasingly vulnerable to certain skin cancers as we age.
The most exciting development is the possibility that some treatments may improve not only how ageing skin looks, but also how it functions.
Nevertheless, the science must be interpreted carefully.
We can improve many consequences of photoageing, reduce further UV damage, treat precancerous changes and potentially modify some age-related cellular responses. But we cannot yet claim to fully reverse skin ageing, restore youthful skin immunity or eliminate skin cancer risk.
The goal of modern skin rejuvenation should therefore be more than smoother, younger-looking skin.
It should be healthier, more resilient skin — supported by proven prevention strategies, evidence-based treatments and appropriate medical surveillance.
Scientific References and Further Reading
Lewis DA et al. The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene, 2010. Read the research.
Chambers ES, Vukmanovic-Stejic M. Skin barrier immunity and ageing. Immunology, 2020. Read the review.
Randomized controlled trial of fractionated laser resurfacing on aged skin as prophylaxis against actinic neoplasia. Journal of Clinical Investigation, 2021. Read the clinical trial.
Weinstock MA et al. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream. JAMA Dermatology, 2018. Read the clinical trial.
Chen AC et al. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. New England Journal of Medicine, 2015. Read the clinical trial.
Guidelines of care for the management of actinic keratosis. American Academy of Dermatology. Read the guideline.
Skin Cancer Prevention and Sun Protection. Cancer Council Australia. Read the guidance.
Medical disclaimer: This article provides general educational information and does not replace an individual clinical assessment. Treatment suitability depends on skin type, medical history, current skin findings and skin cancer risk.